Published in Drugs on January 01, 1991
MRI-based biomechanical imaging: initial study on early plaque progression and vessel remodeling. Magn Reson Imaging (2009) 0.84
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (1988) 27.60
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J (1985) 5.83
Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med (1985) 5.09
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature (1987) 4.54
Circadian variation and triggers of onset of acute cardiovascular disease. Circulation (1989) 4.48
Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res (1983) 4.25
Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med (1978) 3.42
Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation (1988) 3.32
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation (1991) 2.61
Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med (1987) 2.54
Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett (1988) 2.44
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Platelet function in hyperlipoproteinemia. N Engl J Med (1974) 2.23
Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation (1991) 2.23
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest (1990) 2.14
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation (1986) 2.06
A potential basis for the thrombotic risks associated with lipoprotein(a). Nature (1989) 1.93
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (1989) 1.85
Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol (1985) 1.68
Endothelium-derived relaxing factor and coronary vasospasm. Circulation (1989) 1.67
Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow. Biochem Biophys Res Commun (1990) 1.58
Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med (1986) 1.57
Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation (1990) 1.57
Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. J Am Coll Cardiol (1990) 1.56
Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy. Circulation (1981) 1.49
Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science (1983) 1.45
Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm? Circulation (1990) 1.42
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin. Proc Natl Acad Sci U S A (1989) 1.37
Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation (1986) 1.35
Lipoprotein(a). A unique risk factor for atherothrombotic disease. Arteriosclerosis (1990) 1.24
Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis (1986) 1.15
Effect of cholesterol on production of thromboxane b2 by platelets in vitro. N Engl J Med (1980) 1.13
Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides. J Clin Invest (1986) 1.10
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Circ Res (1986) 1.07
Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking. BMJ (1988) 1.05
Plasminogen activator inhibitor in the blood of patients with coronary artery disease. Br Med J (Clin Res Ed) (1985) 1.04
Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. Circulation (1986) 1.04
Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur Heart J (1989) 1.00
Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial. Circulation (1989) 0.99
Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol (1983) 0.99
Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation (1990) 0.96
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation (1988) 0.96
Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol (1989) 0.95
Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries. Biochem Biophys Res Commun (1989) 0.93
Mechanisms of unstable angina. N Engl J Med (1986) 0.93
Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation (1987) 0.92
Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen. Biochemistry (1989) 0.92
Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. J Clin Invest (1989) 0.90
Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med (1987) 0.89
Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. Eur Heart J (1989) 0.88
Plasma catecholamines in acute myocardial infarction. Am Heart J (1979) 0.88
The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation (1988) 0.88
Enhanced production of endothelium-derived contracting factor by endothelial cells subjected to pulsatile stretch. Surgery (1990) 0.88
Frequency of intracoronary filling defects by angiography in angina pectoris at rest. Am J Cardiol (1985) 0.88
Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. Am J Cardiol (1989) 0.86
Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease. J Lab Clin Med (1989) 0.85
Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation (1991) 0.84
Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth. Arteriosclerosis (1990) 0.79
Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis (1985) 0.79
Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arterioscler Thromb (1991) 0.76
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86
Reducing the frequency of errors in medicine using information technology. J Am Med Inform Assoc (2001) 8.37
Coronary plaque disruption. Circulation (1995) 8.04
Idiopathic dilated cardiomyopathy. N Engl J Med (1994) 7.74
The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med (1992) 6.41
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation (1987) 5.73
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
Determinants of HIV-1 shedding in the genital tract of women. Lancet (2001) 5.10
Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol (1985) 4.61
A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb Vasc Biol (1995) 4.43
Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation (1989) 4.32
Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med (1993) 3.90
The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med (1992) 3.53
Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev (1996) 3.49
Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association. Writing Group. Circulation (1996) 3.34
Viruses as precipitants of asthmatic attacks in children. JAMA (1974) 3.30
Restrictive cardiomyopathy. N Engl J Med (1997) 3.29
The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med (1992) 3.16
Hierarchical assembly of cell-matrix adhesion complexes. Biochem Soc Trans (2004) 3.15
Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation (1984) 3.15
Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol (1988) 3.10
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Correlates of certification in family medicine in the billing patterns of Ontario general practitioners. CMAJ (1989) 2.91
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol (2001) 2.77
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest (1990) 2.55
The use of SI units in reporting results obtained in hospital laboratories. J Clin Pathol (1974) 2.55
Population health and health care use: an information system for policy makers. Milbank Q (1996) 2.54
Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation (1996) 2.46
The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol (1981) 2.44
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41
Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology (2010) 2.38
Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res (2001) 2.35
Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol (1990) 2.30
Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation (2000) 2.29
Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation (1995) 2.29
Platelet-active drugs : the relationships among dose, effectiveness, and side effects. Chest (2001) 2.25
Physicians certified in family medicine. What are they doing 8 to 10 years later? Can Fam Physician (2001) 2.21
Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis (1976) 2.20
Radial artery harvesting for coronary bypass operations: neurologic complications and their potential mechanisms. J Thorac Cardiovasc Surg (2001) 2.18
What do outpatients value most in their anesthesia care? Can J Anaesth (2001) 2.18
Association of race and gender with HIV-1 RNA levels and immunologic progression. J Acquir Immune Defic Syndr (2000) 2.13
Greater frequency of viral respiratory infections in asthmatic children as compared with their nonasthmatic siblings. J Pediatr (1974) 2.09
Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med (1969) 2.09
Mortality related to cardiac catheterization and angiography. Cathet Cardiovasc Diagn (1982) 2.08
Plastic surgery of the face in Byzantium in the fourth century. Plast Reconstr Surg (1998) 2.06
Female and Male Physicians: Different Practice Profiles: Will increasing numbers of female GPs affect practice patterns of the future? Can Fam Physician (1991) 2.05
Low-dose aspirin and stroke. "It ain't necessarily so". Stroke (1992) 2.04
The diabetes epidemic in Australia: prevalence, patterns and the public health. Med J Aust (1995) 2.03
Sex differences in management and outcome after acute myocardial infarction in the 1990s: A prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation (2000) 2.02
Effects of atracurium and pancuronium on the oculocardiac reflex in children. Anesth Analg (1991) 2.02
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.01
Screening for diabetic retinopathy. Med J Aust (1995) 1.98
Management of stable coronary artery disease. Am Fam Physician (1997) 1.97
Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation (1999) 1.94
Cloned endogenous retroviral sequences from human DNA. Proc Natl Acad Sci U S A (1982) 1.94
Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation (1996) 1.94
Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation (1998) 1.94
Case studies in partner violence. Am Fam Physician (1999) 1.94
Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest (1996) 1.92
AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (1999) 1.92
ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships. Virology (1984) 1.92
Hybridization of mitochondrial transfer RNA's with mitochondrial and nuclear DNA of grande (wild type) yeast. J Mol Biol (1972) 1.90
Cardiovascular disease in women. Circulation (1993) 1.87
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations. N Engl J Med (1984) 1.85
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med (1982) 1.82
Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol (2000) 1.81
Early ambulation after 5 French diagnostic cardiac catheterization: results of a multicenter trial. J Am Coll Cardiol (1990) 1.76
Insulin syringes: dangers of dead space. Med J Aust (1982) 1.74
The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol (2001) 1.74
Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation (1986) 1.74